logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Li Zhu

Nantong University
H指数:41
被引数:5,990

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Novel Empirical Autoinduction Model to Characterize the Population Pharmacokinetics and Recommend Dose for Repotrectinib in Adult and Adolescents With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

一种新的经验性自诱导模型，用于表征携带ALK、ROS1或NTRK1-3重排的成年人和青少年晚期实体瘤患者的群体药代动力学，并推荐Repotrectinib的剂量

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
IF3
2025-05-010
OAAI
Shengnan Du; Zheyi Hu; Jun Shen; Lora Hamuro; Justine Lam; Ming Lu; Li Zhu; Amit Roy; Anna Kondic
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908
NEURO-ONCOLOGY
IF13.4
2023-02-2020
OAAI
Dunkel, Ira J.; Doz, Francois; Foreman, Nicholas K.; Hargrave, Darren; Lassaletta, Alvaro; Andre, Nicolas; Hansford, Jordan R.; Hassall, Tim; Eyrich, Matthias; Gururangan, Sridharan; Bartels, Ute; Gajjar, Amar; Howell, Lisa; Warad, Deepti; Pacius, Misena; Tam, Rachel; Wang, Yu; Zhu, Li; Cohen, Kenneth

研究方向

暂未获取到该数据
Y
Yapeng Lu
H 指数:24论文数:51被引数:1,455
Y
Ya Ke
H 指数:47论文数:180被引数:6,339
X
Xueting Wang
H 指数:21论文数:81被引数:1,852
Q
Qianqian Luo
H 指数:20论文数:89被引数:1,228
F
Fang Du
H 指数:41论文数:306被引数:4,451
钱
钱忠明
H 指数:49论文数:179被引数:8,486
Z
Zhongping Chen
H 指数:21论文数:77被引数:1,555
Y
Yuan Zhong
H 指数:22论文数:68被引数:1,559
X
Xiaomei Wu
H 指数:30论文数:159被引数:2,697
张琨 封面图
张琨
H 指数:68论文数:797被引数:2.1万